{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:00:30Z","timestamp":1791309630912,"version":"4.3.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T00:00:00Z","timestamp":1280880000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s10549-010-1072-z","type":"journal-article","created":{"date-parts":[[2010,8,3]],"date-time":"2010-08-03T11:49:35Z","timestamp":1280836175000},"page":"109-117","source":"Crossref","is-referenced-by-count":45,"title":["Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells"],"prefix":"10.1007","volume":"128","author":[{"given":"Lev M.","family":"Berstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Santen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,4]]},"reference":[{"issue":"3","key":"1072_CR1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.2009.23.1274","volume":"28","author":"M Dowsett","year":"2010","unstructured":"Dowsett M, Cuzick J, Ingle J, Coates A, Forbes J, Bliss J, Buyse M, Baum M, Buzdar A, Colleoni M, Coombes C, Snowdon C, Gnant M, Jakesz R, Kaufmann M, Boccardo F, Godwin J, Davies C, Peto R (2010) Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus TAM. J Clin Oncol 28(3):509\u2013518","journal-title":"J Clin Oncol"},{"issue":"3","key":"1072_CR2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/1740774509105380","volume":"6","author":"A Giobbie-Hurder","year":"2009","unstructured":"Giobbie-Hurder A, Price KN, Gelber RD, International Breast Cancer Study Group, BIG 1\u201398 Collaborative Group (2009) Design, conduct, and analyses of Breast International Group (BIG) 1\u201398: a randomized, double-blind, phase-III study comparing letrozole and TAM as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer. Clin Trials 6(3):272\u2013287","journal-title":"Clin Trials"},{"issue":"13","key":"1072_CR3","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.ejca.2009.05.032","volume":"45","author":"H Brauch","year":"2009","unstructured":"Brauch H, Jordan VC (2009) Targeting of TAM to enhance antitumour action for the treatment, prevention of breast cancer: the \u2018personalised\u2019 approach? Eur J Cancer 45(13):2274\u20132283","journal-title":"Eur J Cancer"},{"key":"1072_CR4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1102\/1470-7330.2008.0020","volume":"8","author":"SA Polin","year":"2008","unstructured":"Polin SA, Ascher SM (2008) The effect of tamoxifen on the genital tract. Cancer Imaging 8:135\u2013145","journal-title":"Cancer Imaging"},{"issue":"9","key":"1072_CR5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nrc2713","volume":"9","author":"EA Musgrove","year":"2009","unstructured":"Musgrove EA, Sutherland RL (2009) Biological determinants of endocrine resistance in breast cancer. Nat Rev Cancer 9(9):631\u2013643","journal-title":"Nat Rev Cancer"},{"issue":"47","key":"1072_CR6","doi-asserted-by":"crossref","first-page":"7316","DOI":"10.1038\/sj.onc.1206937","volume":"22","author":"R Clarke","year":"2003","unstructured":"Clarke R, Liu MC, Bouker KB, Gu Z, Lee RY, Zhu Y, Skaar TC, Gomez B, O\u2019Brien K, Wang Y, Hilakivi-Clarke LA (2003) Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling. Oncogene 22(47):7316\u20137339","journal-title":"Oncogene"},{"issue":"2 Pt 2","key":"1072_CR7","doi-asserted-by":"crossref","first-page":"865s","DOI":"10.1158\/1078-0432.865s.11.2","volume":"11","author":"CK Osborne","year":"2005","unstructured":"Osborne CK, Shou J, Massarweh S, Schiff R (2005) Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. Clin Cancer Res 11(2 Pt 2):865s\u2013870s","journal-title":"Clin Cancer Res"},{"key":"1072_CR8","doi-asserted-by":"crossref","unstructured":"Gee JM, Howell A, Gullick WJ, Benz CC, Sutherland RL, Santen RJ, Martin LA, Ciardiello F, Miller WR, Dowsett M, Barrett-Lee P, Robertson JF, Johnston SR, Jones HE, Wakeling AE, Duncan R, Nicholson RI (2005) Consensus statement. Workshop on therapeutic resistance in breast cancer: impact of growth factor signalling pathways and implications for future treatment. Endocr Relat Cancer Suppl 1: S1\u2013S7","DOI":"10.1677\/erc.1.01054"},{"issue":"12","key":"1072_CR9","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.2165\/00003495-200161120-00004","volume":"61","author":"LC Dorssers","year":"2001","unstructured":"Dorssers LC, Van der Flier S, Brinkman A, van Agthoven T, Veldscholte J, Berns EM, Klijn JG, Beex LV, Foekens JA (2001) Tamoxifen resistance in breast cancer: elucidating mechanisms. Drugs 61(12):1721\u20131733","journal-title":"Drugs"},{"issue":"1\u20135","key":"1072_CR10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0960-0760(01)00151-0","volume":"79","author":"R Santen","year":"2001","unstructured":"Santen R, Jeng MH, Wang JP, Song R, Masamura S, McPherson R, Santner S, Yue W, Shim WS (2001) Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients. J Steroid Biochem Mol Biol 79(1\u20135):115\u2013125","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1072_CR11","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1677\/erc.1.01018","volume":"Suppl 1","author":"RJ Santen","year":"2005","unstructured":"Santen RJ, Song RX, Zhang Z, Kumar R, Jeng MH, Masamura A, Lawrence J Jr, Berstein L, Yue W (2005) Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity. Endocr Relat Cancer Suppl 1:S61\u2013S73","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"1072_CR12","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/onc.2008.405","volume":"28","author":"J Wen","year":"2009","unstructured":"Wen J, Li R, Lu Y, Shupnik MA (2009) Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor\u2013coregulator interactions. Oncogene 28(4):575\u2013586","journal-title":"Oncogene"},{"issue":"1","key":"1072_CR13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/mnfr.200700470","volume":"53","author":"S Rodr\u00edguez-Enr\u00edquez","year":"2009","unstructured":"Rodr\u00edguez-Enr\u00edquez S, Mar\u00edn-Hern\u00e1ndez A, Gallardo-P\u00e9rez JC, Carre\u00f1o-Fuentes L, Moreno-S\u00e1nchez R (2009) Targeting of cancer energy metabolism. Mol Nutr Food Res 53(1):29\u201348","journal-title":"Mol Nutr Food Res"},{"issue":"2","key":"1072_CR14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.canlet.2004.11.011","volume":"224","author":"LM Berstein","year":"2005","unstructured":"Berstein LM (2005) Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer. Cancer Lett 224(2):203\u2013212","journal-title":"Cancer Lett"},{"key":"1072_CR15","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.2337\/dc08-2175","volume":"32","author":"G Libby","year":"2009","unstructured":"Libby G, Donnely LA, Donnan PT, Alessi DR, Morris AD, Evans JM (2009) New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care 32:1620\u20131625","journal-title":"Diabetes Care"},{"key":"1072_CR16","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2337\/dc09-1791","volume":"33","author":"M Bodmer","year":"2010","unstructured":"Bodmer M, Meier Ch, Krahlenbuhl S, Jick SS, Meier CR (2010) Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care 33:1304\u20131308","journal-title":"Diabetes Care"},{"key":"1072_CR17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.exger.2005.07.007","volume":"40","author":"VN Anisimov","year":"2005","unstructured":"Anisimov VN, Berstein LM, Egormin PA, Piskunova TS, Popovich IG, Zabezhinski MA, Kovalenko IG, Poroshina TE, Semenchenko AV, Provinciali M, Re F, Franceschi C (2005) Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2\/neu transgenic mice. Exp Gerontol 40:685\u2013693","journal-title":"Exp Gerontol"},{"key":"1072_CR18","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1158\/0008-5472.CAN-06-1500","volume":"66","author":"M Zakikhani","year":"2006","unstructured":"Zakikhani M, Dowling R, Fantus IG, Sonenberg N, Pollak M (2006) Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res 66:10269\u201310273","journal-title":"Cancer Res"},{"key":"1072_CR19","doi-asserted-by":"crossref","first-page":"10804","DOI":"10.1158\/0008-5472.CAN-07-2310","volume":"67","author":"RJ Dowling","year":"2007","unstructured":"Dowling RJ, Zakikhani M, Fantus IG, Pollak M, Sonenberg N (2007) Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. Cancer Res 67:10804\u201310812","journal-title":"Cancer Res"},{"key":"1072_CR20","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4161\/cc.8.6.7933","volume":"8","author":"IN Alimova","year":"2009","unstructured":"Alimova IN, Liu B, Fan Z, Edgerton SM, Dillon T, Lind SE, Thor AD (2009) Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro. Cell Cycle 8:909\u2013915","journal-title":"Cell Cycle"},{"key":"1072_CR21","doi-asserted-by":"crossref","unstructured":"Zhuang Y, Miskimins WK (2008) Cell cycle arrest in Metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires p27Kip1 or p21Cip1. J Mol Signal 3: 18","DOI":"10.1186\/1750-2187-3-18"},{"issue":"19","key":"1072_CR22","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1158\/0008-5472.CAN-09-2994","volume":"69","author":"HA Hirsch","year":"2009","unstructured":"Hirsch HA, Iliopoulos D, Tsichlis PN, Struhl K (2009) Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res 69(19):7507\u20137511","journal-title":"Cancer Res"},{"key":"1072_CR23","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1200\/JCO.2009.19.6410","volume":"27","author":"S Jiralerspong","year":"2009","unstructured":"Jiralerspong S, Palla SL, Giordano SH, Meric-Bernstam F, Liedtke C, Barnett CM, Hsu L, Hung MC, Hortobagyi GN, Gonzalez-Angulo AM (2009) Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol 27:3297\u20133302","journal-title":"J Clin Oncol"},{"key":"1072_CR24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3816\/CBC.2008.n.060","volume":"8","author":"PJ Goodwin","year":"2008","unstructured":"Goodwin PJ, Pritchard KI, Ennis M, Clemons M, Graham M, Fantus IG (2008) Insulin-lowering effects of metformin in women with early breast cancer. Clin Breast Cancer 8:501\u2013505","journal-title":"Clin Breast Cancer"},{"issue":"20","key":"1072_CR25","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1200\/JCO.2009.22.1630","volume":"27","author":"PJ Goodwin","year":"2009","unstructured":"Goodwin PJ, Ligibel JA, Stambolic V (2009) Metformin in breast cancer: time for action. J Clin Oncol 27(20):3271\u20133273","journal-title":"J Clin Oncol"},{"key":"1072_CR26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2217\/fon.09.2","volume":"5","author":"LM Berstein","year":"2009","unstructured":"Berstein LM (2009) Metformin, insulin, breast cancer and more. Future Oncol 5:309\u2013312","journal-title":"Future Oncol"},{"key":"1072_CR27","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1158\/1055-9965.EPI-08-0871","volume":"18","author":"M Cazzaniga","year":"2009","unstructured":"Cazzaniga M, Bonanni B, Guerrieri-Gonzaga A, Decensi A (2009) Is it time to test metformin in breast cancer clinical trials? Cancer Epidemiol Biomarkers Prev 18:701\u2013705","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1072_CR28","doi-asserted-by":"crossref","unstructured":"Vazquez-Martin A, Oliveras-Ferraros C, Barco SD, Martin-Castillo B, Menendez JA (2010) The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells. Breast Cancer Res Treat May 11,2010 [Epub ahead of print]","DOI":"10.1007\/s10549-010-0924-x"},{"key":"1072_CR29","unstructured":"Metformin and cancer. http:\/\/ClinicalTrials.gov . Approached on June 30, 2010"},{"key":"1072_CR30","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1158\/0008-5472.CAN-09-0108","volume":"69","author":"KA Brown","year":"2009","unstructured":"Brown KA, McInnes KJ, Hunger NI, Oakhill JS, Steinberg GR, Simpson ER (2009) Subcellular localization of cyclic AMP-responsive element binding protein-regulated transcription coactivator 2 provides a link between obesity and breast cancer in postmenopausal women. Cancer Res 69:5392\u20135399","journal-title":"Cancer Res"},{"issue":"10","key":"1072_CR31","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1210\/jc.80.10.2918","volume":"80","author":"S Masamura","year":"1995","unstructured":"Masamura S, Santner SJ, Heitjan DF, Santen RJ (1995) Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells. J Clin Endocrinol Metab 80(10):2918\u20132925","journal-title":"J Clin Endocrinol Metab"},{"key":"1072_CR32","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jsbmb.2007.05.008","volume":"106","author":"W Yue","year":"2007","unstructured":"Yue W, Fan P, Wang J, Li Y, Santen RJ (2007) Mechanisms of acquired resistance to endocrine therapy in hormone-dependent breast cancer cells. J Steroid Biochem Mol Biol 106:102\u2013110","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"1072_CR33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1677\/erc.0.0100267","volume":"10","author":"LM Berstein","year":"2003","unstructured":"Berstein LM, Zheng H, Yue W, Wang JP, Lykkesfeldt AE, Naftolin F, Harada H, Shanabrough M, Santen RJ (2003) New approaches to the understanding of tamoxifen action and resistance. Endocr Relat Cancer 10(2):267\u2013277","journal-title":"Endocr Relat Cancer"},{"key":"1072_CR34","doi-asserted-by":"crossref","unstructured":"Brown KA, Hunger NI, Docanto M, Simpson ER (2010) Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase. Breast Cancer Res Treat Mar 19, 2010 [Epub ahead of print]","DOI":"10.1007\/s10549-010-0834-y"},{"key":"1072_CR35","doi-asserted-by":"crossref","unstructured":"Berstein LM, Boyarkina MP, Tsyrlina EV, Turkevich EA, Semiglazov VF (2010) More favorable progesterone receptor phenotype of breast cancer in diabetics treated with metformin. Med Oncol May 20, 2010 [Epub ahead of print]","DOI":"10.1007\/s12032-010-9572-6"},{"key":"1072_CR36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejogrb.2009.04.034","volume":"145","author":"E Erdemoglu","year":"2009","unstructured":"Erdemoglu E, G\u00fcney M, Giray SG, Take G, Mungan T (2009) Effects of metformin on mammalian target of rapamycin in a mouse model of endometrial hyperplasia. Eur J Obstet Gynecol Reprod Biol 145:195\u2013199","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1072_CR37","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc2676","volume":"9","author":"DB Shackelford","year":"2009","unstructured":"Shackelford DB, Shaw RJ (2009) The LKB1\u2013AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer 9:563\u2013575","journal-title":"Nat Rev Cancer"},{"issue":"4 Pt 2","key":"1072_CR38","doi-asserted-by":"crossref","first-page":"6S88","DOI":"10.1016\/S1262-3636(03)72792-X","volume":"29","author":"XM Leverve","year":"2003","unstructured":"Leverve XM, Guigas B, Detaille D, Batandier C, Koceir EA, Chauvin C, Fontaine E, Wiernsperger NF (2003) Mitochondrial metabolism and type-2 diabetes: a specific target of metformin. Diabetes Metab 29(4 Pt 2):6S88\u20136S94","journal-title":"Diabetes Metab"},{"issue":"5","key":"1072_CR39","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cmet.2010.03.014","volume":"11","author":"A Kalender","year":"2010","unstructured":"Kalender A, Selvaraj A, Kim SY, Gulati P, Br\u00fbl\u00e9 S, Viollet B, Kemp BE, Bardeesy N, Dennis P, Schlager JJ, Marette A, Kozma SC, Thomas G (2010) Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. Cell Metab 11(5):390\u2013401","journal-title":"Cell Metab"},{"key":"1072_CR40","doi-asserted-by":"crossref","unstructured":"Zakikhani M, Blouin MJ, Piura E, Pollak MN (2010) Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells. Breast Cancer Res Treat Feb 5, 2010 [Epub ahead of print]","DOI":"10.1007\/s10549-010-0763-9"},{"key":"1072_CR41","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.bbrc.2009.02.154","volume":"382","author":"NH Rogers","year":"2009","unstructured":"Rogers NH, Witczak CA, Hirshman MF, Goodyear LJ, Greenberg AS (2009) Estradiol stimulates Akt, AMP-activated protein kinase (AMPK) and TBC1D1\/4, but not glucose uptake in rat soleus. Biochem Biophys Res Commun 382:646\u2013650","journal-title":"Biochem Biophys Res Commun"},{"key":"1072_CR42","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1091\/mbc.E08-11-1138","volume":"20","author":"S Nath-Sain","year":"2009","unstructured":"Nath-Sain S, Marignani PA (2009) LKB1 catalytic activity contributes to estrogen receptor alpha signaling. Mol Biol Cell 20:2785\u20132795","journal-title":"Mol Biol Cell"},{"key":"1072_CR43","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.4161\/cc.8.13.8814","volume":"8","author":"B Liu","year":"2009","unstructured":"Liu B, Fan Z, Edgerton SM, Deng XS, Alimova IN, Lind SE, Thor AD (2009) Metformin induces unique biological and molecular responses in triple negative breast cancer cells. Cell Cycle 8:2031\u20132040","journal-title":"Cell Cycle"},{"issue":"12","key":"1072_CR44","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1634\/theoncologist.12-12-1395","volume":"2","author":"F Lefranc","year":"2007","unstructured":"Lefranc F, Facchini V, Kiss R (2007) Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. Oncologist 2(12):1395\u20131403","journal-title":"Oncologist"},{"key":"1072_CR45","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1210\/jc.2006-2486","volume":"92","author":"Y Takemura","year":"2007","unstructured":"Takemura Y, Osuga Y, Yoshino O, Hasegawa A, Hirata T, Hirota Y, Nose E, Morimoto C, Harada M, Koga K, Tajima T, Yano T, Taketani Y (2007) Metformin suppresses interleukin (IL)-1beta-induced IL-8 production, aromatase activation, and proliferation of endometriotic stromal cells. J Clin Endocrinol Metab 92:3213\u20133218","journal-title":"J Clin Endocrinol Metab"},{"key":"1072_CR46","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1210\/jc.82.1.200","volume":"82","author":"SJ Santner","year":"1997","unstructured":"Santner SJ, Pauley RJ, Tait L, Kaseta J, Santen RJ (1997) Aromatase activity and expression in breast cancer and benign breast tissue stromal cells. J Clin Endocrinol Metab 82:200\u2013208","journal-title":"J Clin Endocrinol Metab"},{"key":"1072_CR47","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1210\/en.2009-0540","volume":"150","author":"S Rice","year":"2009","unstructured":"Rice S, Pellatt L, Ramanathan K, Whitehead SA, Mason HD (2009) Metformin inhibits aromatase via an ERK (extracellular signal-regulated kinase)\u2014mediated pathway. Endocrinology 150:4794\u20134801","journal-title":"Endocrinology"},{"issue":"56","key":"1072_CR48","doi-asserted-by":"crossref","first-page":"8343","DOI":"10.1038\/sj.onc.1208985","volume":"24","author":"Y Hu","year":"2005","unstructured":"Hu Y, Ghosh S, Amleh A, Yue W, Lu Y, Katz A, Li R (2005) Modulation of aromatase expression by BRCA1: a possible link to tissue-specific tumor suppression. Oncogene 24(56):8343\u20138348","journal-title":"Oncogene"},{"key":"1072_CR49","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.bjc.6602935","volume":"94","author":"S Fan","year":"2006","unstructured":"Fan S, Meng Q, Auborn K, Carter T, Rosen EM (2006) BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br J Cancer 94:407\u2013426","journal-title":"Br J Cancer"},{"key":"1072_CR50","unstructured":"Ivanov VG, Tsyrlina EV, Kovalenko IG, Poroshina TE, Gamaiunova VB, Malysheva SA, Zhil\u2019tsova EK, Barash NIu, Shcherbakova EB, Semiglazov VF, Bershte\u012dn LM (2006) [Correlation of hormone-metabolic status in breast cancer with effectiveness of adjuvant hormone therapy] Vopr Onkol 52: 150\u2013154 (in Russian)"},{"key":"1072_CR51","doi-asserted-by":"crossref","first-page":"9512","DOI":"10.1158\/0008-5472.CAN-08-0553","volume":"68","author":"H Johansson","year":"2008","unstructured":"Johansson H, Gandini S, Guerrieri-Gonzaga A, Iodice S, Ruscica M, Bonanni B, Gulisano M, Magni P, Formelli F, Decensi A (2008) Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancer. Cancer Res 68:9512\u20139518","journal-title":"Cancer Res"},{"issue":"6","key":"1072_CR52","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1158\/1078-0432.CCR-09-1805","volume":"16","author":"AM Gonzalez-Angulo","year":"2010","unstructured":"Gonzalez-Angulo AM, Meric-Bernstam F (2010) Metformin: a therapeutic opportunity in breast cancer. Clin Cancer Res 16(6):1695\u20131700","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1072_CR53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10549-008-0015-4","volume":"114","author":"V Stambolic","year":"2009","unstructured":"Stambolic V, Woodgett JR, Fantus IG, Pritchard KI, Goodwin PJ (2009) Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor? Breast Cancer Res Treat 114(2):387\u2013389","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1072_CR54","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ygyno.2009.09.024","volume":"116","author":"LA Cantrell","year":"2010","unstructured":"Cantrell LA, Zhou C, Mendivil A, Malloy KM, Gehrig PA, Bae-Jump VL (2010) Metformin is a potent inhibitor of endometrial cancer cell proliferation\u2014implications for a novel treatment strategy. Gynecol Oncol 116(1):92\u201398","journal-title":"Gynecol Oncol"},{"issue":"2","key":"1072_CR55","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1463-1326.2003.00241.x","volume":"5","author":"JD Lalau","year":"2003","unstructured":"Lalau JD, Lacroix C (2003) Measurement of metformin concentration in erythrocytes: clinical implications. Diabetes Obes Metab 5(2):93\u201398","journal-title":"Diabetes Obes Metab"},{"key":"1072_CR56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/00498259409043220","volume":"24","author":"C Wilcock","year":"1994","unstructured":"Wilcock C, Bailey CJ (1994) Accumulation of metformin by tissues of the normal and diabetic mouse. Xenobiotica 24:49\u201357","journal-title":"Xenobiotica"},{"key":"1072_CR57","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1158\/1078-0432.CCR-03-0538","volume":"10","author":"ER Kisanga","year":"2004","unstructured":"Kisanga ER, Gjerde J, Guerrieri-Gonzaga A, Pigatto F, Pesci-Feltri A, Robertson C, Serrano D, Pelosi G, Decensi A, Lien EA (2004) Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial. Clin Cancer Res 10:2336\u20132343","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1072_CR58","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10549-008-9916-5","volume":"113","author":"KN Phoenix","year":"2009","unstructured":"Phoenix KN, Vumbaca F, Claffey KP (2009) Therapeutic metformin\/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model breast cancer. Res Treat 113(1):101\u2013111","journal-title":"Res Treat"},{"issue":"2","key":"1072_CR59","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10549-008-0016-3","volume":"114","author":"SM Hadad","year":"2009","unstructured":"Hadad SM, Appleyard V, Thompson AM (2009) Therapeutic metformin\/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model. Breast Cancer Res Treat 114(2):391","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-1072-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-010-1072-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-1072-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T15:13:44Z","timestamp":1685718824000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-010-1072-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,4]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["1072"],"URL":"https:\/\/doi.org\/10.1007\/s10549-010-1072-z","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,4]]}}}